SI21370A - Nove soli antikonvulzantnih derivatov - Google Patents
Nove soli antikonvulzantnih derivatov Download PDFInfo
- Publication number
- SI21370A SI21370A SI200220021A SI200220021A SI21370A SI 21370 A SI21370 A SI 21370A SI 200220021 A SI200220021 A SI 200220021A SI 200220021 A SI200220021 A SI 200220021A SI 21370 A SI21370 A SI 21370A
- Authority
- SI
- Slovenia
- Prior art keywords
- common
- salt
- formula
- compound
- topiramate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30396201P | 2001-07-09 | 2001-07-09 | |
| PCT/US2002/021016 WO2003006467A1 (en) | 2001-07-09 | 2002-07-03 | Novel anticonvulsant derivative salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI21370A true SI21370A (sl) | 2004-06-30 |
Family
ID=23174444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200220021A SI21370A (sl) | 2001-07-09 | 2002-07-03 | Nove soli antikonvulzantnih derivatov |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US7098188B2 (zh) |
| EP (1) | EP1414824B1 (zh) |
| JP (1) | JP2005502629A (zh) |
| KR (1) | KR20040013127A (zh) |
| CN (1) | CN1288159C (zh) |
| AR (1) | AR036137A1 (zh) |
| AT (1) | ATE361304T1 (zh) |
| AU (1) | AU2002346042B2 (zh) |
| BR (1) | BR0211063A (zh) |
| CA (1) | CA2452612A1 (zh) |
| DE (1) | DE60219922T2 (zh) |
| DK (1) | DK1414824T3 (zh) |
| ES (1) | ES2284884T3 (zh) |
| HK (1) | HK1064094A1 (zh) |
| HR (1) | HRP20040017A2 (zh) |
| HU (1) | HUP0401080A2 (zh) |
| IL (2) | IL159698A0 (zh) |
| MX (1) | MXPA04000232A (zh) |
| NO (1) | NO20040066L (zh) |
| NZ (1) | NZ530507A (zh) |
| PL (1) | PL367635A1 (zh) |
| PT (1) | PT1414824E (zh) |
| RU (1) | RU2320665C2 (zh) |
| SI (1) | SI21370A (zh) |
| UA (1) | UA78211C2 (zh) |
| WO (1) | WO2003006467A1 (zh) |
| ZA (1) | ZA200400970B (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA78211C2 (en) | 2001-07-09 | 2007-03-15 | Ortho Mcneil Pharm Inc | Salts of fructopyranose derivatives as anticonvulsant |
| US7041650B2 (en) * | 2001-07-09 | 2006-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivative salts |
| JP2005508373A (ja) * | 2001-11-06 | 2005-03-31 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 抗痙攣剤誘導体およびカリウムを用いる共同療法を含んでなる感覚異常の処置および予防 |
| US20030224006A1 (en) | 2002-03-01 | 2003-12-04 | Zaworotko Michael J. | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| US20090088443A1 (en) * | 2002-02-15 | 2009-04-02 | Julius Remenar | Novel crystalline forms of conazoles and methods of making and using the same |
| US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US20100311701A1 (en) * | 2002-02-15 | 2010-12-09 | Transform Pharmaceuticals, Inc | Pharmaceutical Co-Crystal Compositions |
| US20070059356A1 (en) * | 2002-05-31 | 2007-03-15 | Almarsson Oern | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| JP2006500377A (ja) * | 2002-06-21 | 2006-01-05 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 改善された溶解性を有する医薬組成物 |
| US8183290B2 (en) * | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US20060088886A1 (en) * | 2004-10-25 | 2006-04-27 | Anlong Ouyang | Topiramate analogs |
| US7638291B2 (en) | 2004-10-25 | 2009-12-29 | Seradyn, Inc. | Immunoassays for topiramate |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9489372B2 (en) * | 2013-03-15 | 2016-11-08 | Apple Inc. | Web-based spell checker |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| TWI826531B (zh) | 2018-09-21 | 2023-12-21 | 南韓商愛思開生物製藥股份有限公司 | 具有㗁二唑之化合物及包含該化合物之醫藥組合物 |
| US20210169844A1 (en) | 2019-12-10 | 2021-06-10 | Tulex Pharmaceuticals Inc. | Compositions and methods for treating epilepsy, seizures and other conditions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513008A (en) * | 1982-07-30 | 1985-04-23 | The Vinoxen Company, Inc. | Virucidal compositions and therapy |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| AU651244B2 (en) * | 1991-09-19 | 1994-07-14 | Mcneilab, Inc. | Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| US5498629A (en) * | 1993-12-23 | 1996-03-12 | Ortho Pharmaceutical Corporation | Anticonvulsant pseudofructopyranose sulfamates |
| US5998380A (en) | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
| US5952187A (en) * | 1995-12-01 | 1999-09-14 | Oxis International, Inc. | Topiramate immunoassay |
| US6541520B1 (en) | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| JP2002537326A (ja) * | 1999-02-24 | 2002-11-05 | ユニヴァーシティ・オブ・シンシナティ | 衝動調節障害の治療のためのスルファメート誘導体の使用 |
| UA78211C2 (en) * | 2001-07-09 | 2007-03-15 | Ortho Mcneil Pharm Inc | Salts of fructopyranose derivatives as anticonvulsant |
| US7041650B2 (en) * | 2001-07-09 | 2006-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivative salts |
| US6559293B1 (en) | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
-
2002
- 2002-03-07 UA UA2004010229A patent/UA78211C2/uk unknown
- 2002-07-03 SI SI200220021A patent/SI21370A/sl not_active IP Right Cessation
- 2002-07-03 PL PL02367635A patent/PL367635A1/xx not_active Application Discontinuation
- 2002-07-03 CN CNB028172035A patent/CN1288159C/zh not_active Expired - Lifetime
- 2002-07-03 DK DK02744798T patent/DK1414824T3/da active
- 2002-07-03 DE DE60219922T patent/DE60219922T2/de not_active Expired - Lifetime
- 2002-07-03 HU HU0401080A patent/HUP0401080A2/hu unknown
- 2002-07-03 MX MXPA04000232A patent/MXPA04000232A/es active IP Right Grant
- 2002-07-03 AT AT02744798T patent/ATE361304T1/de not_active IP Right Cessation
- 2002-07-03 NZ NZ530507A patent/NZ530507A/en unknown
- 2002-07-03 US US10/188,924 patent/US7098188B2/en not_active Expired - Lifetime
- 2002-07-03 IL IL15969802A patent/IL159698A0/xx unknown
- 2002-07-03 WO PCT/US2002/021016 patent/WO2003006467A1/en active IP Right Grant
- 2002-07-03 JP JP2003512237A patent/JP2005502629A/ja active Pending
- 2002-07-03 CA CA002452612A patent/CA2452612A1/en not_active Abandoned
- 2002-07-03 EP EP02744798A patent/EP1414824B1/en not_active Expired - Lifetime
- 2002-07-03 BR BR0211063-6A patent/BR0211063A/pt not_active IP Right Cessation
- 2002-07-03 PT PT02744798T patent/PT1414824E/pt unknown
- 2002-07-03 KR KR10-2004-7000233A patent/KR20040013127A/ko active IP Right Grant
- 2002-07-03 RU RU2004100274/04A patent/RU2320665C2/ru active
- 2002-07-03 ES ES02744798T patent/ES2284884T3/es not_active Expired - Lifetime
- 2002-07-03 AU AU2002346042A patent/AU2002346042B2/en not_active Ceased
- 2002-07-08 AR ARP020102553A patent/AR036137A1/es unknown
-
2004
- 2004-01-02 IL IL159698A patent/IL159698A/en active IP Right Grant
- 2004-01-08 NO NO20040066A patent/NO20040066L/no not_active Application Discontinuation
- 2004-01-09 HR HR20040017A patent/HRP20040017A2/hr not_active Application Discontinuation
- 2004-02-05 ZA ZA200400970A patent/ZA200400970B/en unknown
- 2004-09-08 HK HK04106824A patent/HK1064094A1/xx not_active IP Right Cessation
-
2006
- 2006-01-09 US US11/327,984 patent/US20060105966A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060105966A1 (en) | Novel anticonvulsant derivative salts | |
| RU2328502C2 (ru) | Новые замещенные сульфаматные противосудорожные производные | |
| RU2197481C2 (ru) | Производные хинолина | |
| WO2018098472A1 (en) | Crm1 inhibitors for treating epilepsy | |
| AU2002346042A1 (en) | Novel anticonvulsant derivative salts | |
| CZ295618B6 (cs) | Pyrazinové deriváty, způsob výroby a farmaceutický prostředek | |
| BRPI0920356B1 (pt) | Processo para a preparação de compostos úteis como inibidores de sglt | |
| BR112012008939B1 (pt) | Processo para a preparação de compostos úteis como inibidores de sglt2 | |
| JP2012502928A (ja) | Ｃｒｔｈ２受容体アンタゴニストとしてのアザインドール誘導体 | |
| KR20160003899A (ko) | 마크롤리드 고체상 형태 | |
| US7041650B2 (en) | Anticonvulsant derivative salts | |
| ZA200402626B (en) | New hydroxyalkylindolocarbazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| US10844018B2 (en) | Pyridoxine derivative for treatment of epilepsy | |
| KR100807894B1 (ko) | 포스핀산 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20100311 |